iuvo BioScience

iuvo Clinical is a privately held, full-service contract research organization dedicated 100% to ophthalmology, positioning itself as a high-touch, high-science partner for drug and device developers. The company boasts a strong track record, having supported the development of 10 of the 23 FDA-approved ophthalmic drugs since its founding in 2008. Its business model is service-based, offering global trial management with a specialized network, and it is clearly in a revenue-generating stage as an established CRO. iuvo's strategic focus on a single therapeutic area allows it to offer tailored expertise and operational precision that generalist CROs may lack.

Integrated operational and scientific expertise model for ophthalmology clinical trials, including specialized protocol design, a global network of investigative sites, and mastery of ophthalmic-specific trial technologies (e.g., imaging reading centers).

iuvo competes primarily within the niche of ophthalmology-focused CROs and against the ophthalmology divisions of large, global full-service CROs (e.g., IQVIA, PPD, Parexel). Its differentiation is its 100% ophthalmology dedication, which promises deeper therapeutic expertise and a more tailored, high-touch partnership compared to larger, less-specialized competitors.